Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.

Melanoma Research
Gladys AlvaradoMichael A Davies

Abstract

Venous thromboembolism (VTE) is a frequent complication in melanoma patients with brain metastases (BM). The management of these patients is challenging because of the high risk of intracranial hemorrhage (ICH) and the limited data available on the safety of anticoagulation in this scenario. We reviewed the treatments and outcomes among melanoma patients with BM and VTE at our institution to determine the safety of anticoagulation in these patients. A retrospective chart review was performed to identify melanoma patients with BM who were diagnosed with VTE. The clinical characteristics of the BM and the VTE, the treatments given for VTE, subsequent ICH, and overall survival (OS) were determined. The characteristics and outcomes were compared between patients who received systemic anticoagulation and those who did not. A total of 74 evaluable melanoma patients with BM and VTE were identified. Fifty-seven (77%) patients received systemic anticoagulation. There was no significant difference in the number (P=0.40) or the maximum diameter (P=0.55) of brain metastasis between the patients who received anticoagulation and those who did not. Two (4%) patients who received anticoagulation developed ICH, which was not statistically diffe...Continue Reading

References

Mar 1, 1983·Annals of Neurology·R L Ruff, J B Posner
Jan 1, 1983·Journal of Neuro-oncology·T N ByrneJ B Posner
Jun 1, 1994·Annals of Internal Medicine·E M Hylek, D E Singer
Jan 15, 1994·Cancer·D Schiff, L M DeAngelis
Oct 8, 2003·The Oncologist·Frederick C Beddingfield
Dec 3, 2003·Expert Opinion on Pharmacotherapy·Agnes Y Y Lee
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jill S Barnholtz-SloanRaymond E Sawaya
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L FineMichael R Fetell
Feb 27, 2007·Journal of Thrombosis and Haemostasis : JTH·A A KhoranaG H Lyman
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth R Gerstner, Robert L Fine
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Oct 21, 2010·Cancer·Michael A DaviesAgop Bedikian
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 14, 2016·Thrombosis Research·Matthew J WeinstockJeffrey I Zwicker
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
Jul 25, 2015·Blood·Lisa Baumann Kreuziger
May 17, 2013·Seminars in Hematology·Axel Matzdorff, Juerg-Hans Beer
Jun 15, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Thorleif EtgenLukas Gsottschneider
Jul 12, 2013·Blood·Agnes Y Y Lee, Erica A Peterson
Nov 2, 2014·Neuro-oncology·David SchiffPatrick Y Wen
Jun 17, 2016·Journal of Thrombosis and Haemostasis : JTH·J I ZwickerM Carrier
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuling Lin, Lisa M DeAngelis
Jun 8, 2015·American Journal of Therapeutics·Pramod Reddy, Lori Dupree
Mar 25, 2018·Journal of Thrombosis and Haemostasis : JTH·P W KamphuisenUNKNOWN CATCH Investigators
Mar 3, 2018·Medical Oncology·Heidi HorstmanNicole A Shonka
Oct 1, 2019·Cancer Medicine·Eric W SankeyPeter E Fecci
Feb 12, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hikmat Abdel-RazeqMohammad Ibrahim
Oct 28, 2016·Journal of Thrombosis and Haemostasis : JTH·C M Rojas-HernandezH A García-Perdomo
Dec 4, 2016·Hematology·Michael B Streiff
Nov 25, 2020·Thrombosis Research·Sergio Lopez-RuzLuis Jara-Palomares
Mar 11, 2021·Journal of Neurology, Neurosurgery, and Psychiatry·Peter WoodAyal Aizer
Mar 21, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Asma Akbar LadakAhmed Itrat
Apr 4, 2021·Cancer Treatment Reviews·Cecilia BecattiniMario Mandalà

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David E GerberMichael B Streiff
Cerebrovascular Diseases
European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee
© 2021 Meta ULC. All rights reserved